Evidence map›Paper›PMID 25821809›Full record

ReviewBioMed research international2015

Antioxidant strategies in the management of diabetic neuropathy.

Ayodeji Babatunde Oyenihi, Ademola Olabode Ayeleso, Emmanuel Mukwevho, Bubuya Masola

2 registry-linked trialsOpen access · hybridAbstract readReview
In one paragraph

Review in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 76 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 1 pooled it
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05422352 nacompletednot on this mapstarted 2021, after this paper: background citation

Role of Carnosine in Combination With Vitamin B Complex in Preventing the Progression of Diabetic Neuropathy in Type 2 Diabetes Patients

TypeinterventionalSponsorBeni-Suef UniversityRan2021 to 2022Enrolled60ConditionsDiabetic NeuropathiesArmsCarnosine
NCT06131918 phase2completednot on this mapstarted 2023, after this paper: background citation

Assessment of Resveratrol, Alpha Lipoic Acid and Superoxide Dismutase on Oxidative Stress Biomarkers in Type 2 Diabetes Mellitus Patients With Neuropathy: A Randomized Control Trial

TypeinterventionalSponsorKhyber Medical University PeshawarRan2023 to 2024Enrolled100ConditionsPeripheral Diabetic NeuropathyArmsResveratrol, Alpha lipoic acid, Super oxide dismutase, Resveratrol, Alpha lipoic acid, Super Oxide Dismutase
3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 1 synthesis or guideline pooled it, 177 citations in OpenAlex.

  1. Journal of alternative and complementary medicine (New York, N.Y.) · 2018
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Review
  7. Role of Mitochondrial Dysfunction in Neuropathy.International journal of molecular sciences · 2025
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Novel drugs affecting diabetic peripheral neuropathy.Iranian journal of basic medical sciences · 2024
    Review
  16. Article
  17. Review
  18. Article
  19. Pharmaceutical biology · 2022
    Article
  20. Review

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ayodeji Babatunde OyenihiDiscipline of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, Westville Campus, Private Bag X54001, University Road, Durban 4000, South Africa.
Ademola Olabode AyelesoDepartment of Biochemistry, University of Johannesburg, P.O. Box 524, Auckland Park 2002, South Africa.
Emmanuel MukwevhoDepartment of Biochemistry, University of Johannesburg, P.O. Box 524, Auckland Park 2002, South Africa.ORCID 0000-0003-3509-6770
Bubuya MasolaDiscipline of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, Westville Campus, Private Bag X54001, University Road, Durban 4000, South Africa.
University of Johannesburg · ZAUniversity of KwaZulu-Natal · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic hyperglycaemia (an abnormally high glucose concentration in the blood) resulting from defects in insulin secretion/action, or both, is the major hallmark of diabetes in which it is known to be involved in the progression of the condition to different complications that include diabetic neuropathy. Diabetic neuropathy (diabetes-induced nerve damage) is the most common diabetic complication and can be devastating because it can lead to disability. There is an increasing body of evidence associating diabetic neuropathy with oxidative stress. Oxidative stress results from the production of oxygen free radicals in the body in excess of its ability to eliminate them by antioxidant activity. Antioxidants have different mechanisms and sites of actions by which they exert their biochemical effects and ameliorate nerve dysfunction in diabetes by acting directly against oxidative damage. This review will examine different strategies for managing diabetic neuropathy which rely on exogenous antioxidants.

Indexed as

Models, ImmunologicalAntioxidantsCytokinesDiabetic NeuropathiesHumansOxidative StressReactive Oxygen SpeciesSignal TransductionAntioxidantsCytokinesReactive Oxygen Species

Identifiers

PMID25821809
PMCPMC4363503
OpenAlexW2043503204

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.